White blood cell BRCA1 promoter methylation status and ovarian cancer risk.
Authors
Lønning, PBerge, E
Bjørnslett, M
Minsaas, L
Chrisanthar, R
Høberg-Vetti, H
Dulary, C
Busato, F
Bjørneklett, S
Eriksen, C
Kopperud, R
Axcrona, U
Davidson, B
Bjørge, L
Evans, G
Howell, Anthony
Salvesen, H
Janszky, I
Hveem, K
Romundstad, P
Vatten, L
Tost, J
Dørum, A
Knappskog, S
Affiliation
University of Bergen and Haukeland University Hospital, Bergen, NorwayIssue Date
2018-03-06
Metadata
Show full item recordAbstract
The role of normal tissue gene promoter methylation in cancer risk is poorly understood.Citation
White blood cell BRCA1 promoter methylation status and ovarian cancer risk. 2018, 168(5): 326-334 Ann Intern MedJournal
Annals of Internal MedicineDOI
10.7326/M17-0101PubMed ID
29335712Type
ArticleLanguage
enISSN
1539-3704ae974a485f413a2113503eed53cd6c53
10.7326/M17-0101
Scopus Count
Collections
Related articles
- BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).
- Authors: Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P, Vergote I, Mahner S, Cacsire-Tong D, Concin N, Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI
- Issue date: 2014 Aug
- Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
- Authors: Lønning PE, Nikolaienko O, Pan K, Kurian AW, Eikesdal HP, Pettinger M, Anderson GL, Prentice RL, Chlebowski RT, Knappskog S
- Issue date: 2022 Nov 1
- Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women.
- Authors: Al-Moghrabi N, Al-Showimi M, Alqahtani A, Almalik O, Alhusaini H, Almalki G, Saad A, Alsunayi E
- Issue date: 2024 Mar 7
- Genetic Versus Epigenetic BRCA1 Silencing Pathways: Clinical Effects in Primary Ovarian Cancer Patients: A Study of the Tumor Bank Ovarian Cancer Consortium.
- Authors: Sun T, Ruscito I, Dimitrova D, Chekerov R, Kulbe H, Baron U, Blanchard V, Panici PB, Darb-Esfahani S, Sehouli J, Olek S, Braicu EI
- Issue date: 2017 Oct
- BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.
- Authors: Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY
- Issue date: 2000 Oct 1